Company Profiles

driven by the PitchBook Platform

Orlucent

Orlucent
2008 FOUNDED
PRIVATE STATUS
Grant LATEST DEAL TYPE
2 INVESTORS
Description

Operator of a diagnostic technology agency designed to be used for early cancer detection. The company's diagnostic technology agency engages in the development of diagnostic tools for melanoma, enabling dermatologists to gather information about melanoma cancer efficiently in real time.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Other Healthcare
Primary Office
750 South California Avenue
Palo Alto, CA 94306
United States
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Orlucent’s full profile, request a free trial.

Orlucent Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Grant 05-Jun-2013 00000 Completed Startup
1. Early Stage VC (Series A) 24-Mar-2010 00000 00000 00.000 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Orlucent Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series A 0,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
To view this company’s complete Cap Table, request access »

Orlucent Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
BIRD Foundation Limited Partner 000 0000 000000 0
Emergent Medical Partners Venture Capital Minority 000 0000 000000 0

Orlucent Executive Team (1)

Name Title Board
Seat
Contact
Info
Cathy Shachaf Ph.D Founder, President and CSO
Questions or concerns about this profile? Reach out to website-support@pitchbook.com